Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2017-08-03 Report Publication Anno…
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC AG: Conference call to be hosted on 10 August 2017 to present the half-year financial report 2017
Report Publication Announcement Classification · 1% confidence The document is a news release dated August 3, 2017, announcing that 4SC AG will publish its 'half-year financial report' on August 10, 2017, and will host a conference call to present these results. The key phrases are 'half-year financial report' and 'conference call to be hosted'. Since the document itself is an announcement about the upcoming release of the financial report and the associated call, it is not the comprehensive report (Interim Report, IR) itself, nor is it the transcript of the call (CT). It is an announcement regarding the publication of a report and the scheduling of a related event. This fits best under Report Publication Announcement (RPA), as it explicitly announces the publication date of the half-year report and provides details for the subsequent conference call.
2017-08-03 English
4SC AG was granted a fundamental composition of matter patent for 4SC-208 for the US
Regulatory Filings Classification · 1% confidence The document is a press release dated August 1, 2017, announcing that 4SC AG was granted a composition of matter patent (US patent No. 9,580,438) for its drug candidate 4SC-208. It details the patent's scope, market exclusivity, and the drug's development timeline (preclinical testing completion in 2018, followed by Phase I/II clinical study). This type of announcement, focusing on intellectual property protection and development milestones, is typically classified as a general corporate news release. Since there is no specific category for 'Patent Grant Announcement' and it is not a formal regulatory filing like a 10-K, nor is it a financial results release (ER) or a management change (MANG), the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate announcements distributed via services like DGAP.
2017-08-01 English
DGAP-DD: 4SC AG english
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains the header 'DGAP-DD: 4SC AG english' followed by 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. Section 1 identifies the person as a 'Member of the administrative or supervisory body' (a director/manager), and Section 4 details the 'transaction(s)' involving the acquisition of shares. This content directly matches the definition for Director's Dealing.
2017-07-24 English
4SC licenses Kv1.3 inhibitors to Maruho
Regulatory Filings Classification · 1% confidence The document is a press release dated July 18, 2017, announcing a licensing agreement between 4SC AG and Maruho Co., Ltd. regarding Kv1.3 inhibitors. It details financial terms (upfront, milestones, royalties) and strategic rationale. This type of announcement, which details a significant corporate transaction (licensing/partnership) and its financial implications, fits best under the 'Capital/Financing Update' (CAP) if it involves raising capital or restructuring debt, or 'Regulatory Filings' (RNS) if it's a general corporate announcement not covered elsewhere. Since this is a specific business development/licensing deal, and there isn't a dedicated 'Partnership/Licensing' code, I must evaluate the closest fit. It is not an earnings release (ER), an interim report (IR), or an annual report (10-K). It is a corporate news item about a major transaction. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for significant, non-standard corporate news releases disseminated via services like DGAP, especially when the core event is a licensing deal rather than a direct capital raise (CAP) or management change (MANG). However, looking closely at the definitions, none perfectly capture a licensing deal. Since it is a significant corporate event announcement disseminated via a news service (DGAP), RNS is the standard fallback. If the deal involved a large cash infusion that significantly altered the capital structure, CAP might be considered, but this is primarily a business development announcement. I will classify it as RNS as the most suitable general regulatory announcement category.
2017-07-18 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German securities law (WpHG). It details changes in the percentage of voting rights held by an entity (Wellington Partners Advisory AG and related funds) in 4SC AG, crossing a threshold on July 11, 2017. This type of filing, reporting changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a specific disclosure of ownership change, which fits MRQ better than the general DVA (Declaration of Voting Results).
2017-07-14 English
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 25.08.2017 in Planegg-Martinsried mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 1% confidence The document is titled 'Bekanntmachung der Einberufung zur Hauptversammlung am 25.08.2017' (Announcement of the Convocation to the Annual General Meeting) and explicitly invites shareholders to the 'ordentlichen Hauptversammlung 2017' (Ordinary Annual General Meeting). The text details the agenda (Tagesordnung) which includes resolutions on discharging management/supervisory boards, appointing auditors, and significant capital structure changes (Genehmigtes Kapital, Bedingtes Kapital). This content is characteristic of materials distributed to shareholders in preparation for an AGM, specifically the notice of meeting and the proposed resolutions. While it contains elements that might be found in a Proxy Statement (PSI) or Governance Report (CGR), the primary function and title clearly identify it as the official notice for the Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R).
2017-07-14 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.